Skip to content 
The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified. more
| Time Frame | WDNA | S&P500 |
|---|---|---|
| 1-Week Return | -4.96% | 1.96% |
| 1-Month Return | 0.9% | 1.72% |
| 3-Month Return | 8.02% | 3.7% |
| 6-Month Return | 30.19% | 18.25% |
| 1-Year Return | 35.68% | 16% |
| 3-Year Return | 54.68% | 81.52% |
| 5-Year Return | -7.17% | 79.14% |
| 10-Year Return | -8.2% | 261.37% |
| Stock name | Ticker | Weight |
|---|---|---|
 Moderna Inc | MRNA | 10.2% |
 Twist Bioscience Corp | TWST | 9.06% |
 10X Genomics Inc-Class A | TXG | 3.65% |
 Eli Lilly & Co | LLY | 3.5% |
 Natera Inc | NTRA | 3.09% |
 Tempus Ai Inc | TEM | 2.92% |
 Johnson & Johnson | JNJ | 2.76% |
 Immunome Inc | IMNM | 2.02% |
 United Therapeutics Corp | UTHR | 1.89% |
 Darling Ingredients Inc | DAR | 1.88% |
 Iovance Biotherapeutics Inc | IOVA | 1.78% |
 Thermo Fisher Scientific Inc | TMO | 1.76% |
 Revolution Medicines Inc | RVMD | 1.6% |
 Gilead Sciences Inc | GILD | 1.59% |
 Corteva Inc | CTVA | 1.59% |
 Roivant Sciences Ltd | ROIV | 1.58% |
 Amgen Inc | AMGN | 1.57% |
 Krystal Biotech Inc | KRYS | 1.55% |
 Crispr Therapeutics Ag | CRSP | 1.54% |
 Stoke Therapeutics Inc | STOK | 1.43% |
 Pfizer Inc | PFE | 1.4% |
 Astrazeneca Plc | AZN.L | 1.4% |
 Bayer AG | BAYN.DE | 1.39% |
 Bunge Global Sa | BG | 1.34% |
 Beam Therapeutics Inc | BEAM | 1.29% |
 Vertex Pharmaceuticals Inc | VRTX | 1.27% |
 Novozymes A/S | NZYM.B.CO | 1.24% |
 Agios Pharmaceuticals Inc | AGIO | 1.24% |
 ABSCI Corp | ABSI | 1.22% |
 Structure Therapeutics Inc | GPCR | 1.21% |
 Biohaven Ltd | BHVN | 1.07% |
 Novartis AG | NOVN.SW | 1.06% |
 Arcturus Therapeutics Hlgs | ARCT | 1.04% |
 Arrowhead Pharmaceuticals Inc | ARWR | 1.04% |
 Protagonist Therapeutics Inc | PTGX | 1.03% |
 Veracyte Inc | VCYT | 0.98% |
 Exelixis Inc | EXEL | 0.98% |
 Isis Pharmaceuticals Inc | IONS | 0.94% |
 Uniqure NV | QURE | 0.91% |
 Repligen Corp | RGEN | 0.9% |
 Argenx Se - Adr | ARGX | 0.84% |
 Biontech Se-ADR | BNTX | 0.82% |
 Halozyme Therapeutics Inc | HALO | 0.81% |
 Danaher Corp | DHR | 0.78% |
 Cg Oncology Inc | CGON | 0.77% |
 Biogen Idec Inc | BIIB | 0.76% |
 Cullinan Therapeutics Inc | CGEM | 0.75% |
 Celldex Therapeutics Inc | CLDX | 0.71% |
 Illumina Inc | ILMN | 0.71% |
 Merck & Co Inc/NJ | MRK | 0.7% |
 Viking Therapeutics Inc | VKTX | 0.68% |
 Editas Medicine Inc | EDIT | 0.65% |
 Syensqo Sa | SYENS.BR | 0.64% |
 Dyne Therapeutics Inc | DYN | 0.64% |
 Regeneron Pharmaceuticals Inc | REGN | 0.58% |
 Verbio AG | VBK.DE | 0.57% |
 Allogene Therapeutics Inc | ALLO | 0.56% |
 Insmed Inc | INSM | 0.55% |
 Regenxbio Inc | RGNX | 0.51% |
 Oxford Nanopore Technologies | ONT.L | 0.51% |
 Green Plains Inc | GPRE | 0.49% |
 Nufarm Ltd/Australia | NUF.AX | 0.49% |
 Sana Biotechnology Inc | SANA | 0.49% |
 Genmab A/S -Sp ADR | GMAB | 0.48% |
 Techne Corp | TECH | 0.43% |
 FMC Corp | FMC | 0.4% |
 BioMarin Pharmaceutical Inc | BMRN | 0.4% |
 Bridgebio Pharma Inc | BBIO | 0.37% |
 Intellia Therapeutics Inc | NTLA | 0.31% |
 Zoetis Inc | ZTS | 0.31% |
 Genus Plc | GNS.L | 0.3% |
 Geron Corp | GERN | 0.28% |
 Sarepta Therapeutics Inc | SRPT | 0.27% |
 QIAGEN N.V. | QGEN | 0.25% |
 Pacific Biosciences Of Calif | PACB | 0.25% |
 Tyson Foods Inc | TSN | 0.23% |
 Ultragenyx Pharmaceutical Inc | RARE | 0.23% |
 Alnylam Pharmaceuticals Inc | ALNY | 0.22% |
 Rocket Pharmaceuticals Inc | RCKT | 0.19% |
 DREYFUS TRSY OBLIG CASH MGMT CL INS | DREYFUS.TRSY.OBLIG.CASH.MGMT.CL.INS | 0.17% |
 US DOLLAR | US.DOLLAR | 0% |
 DANISH KRONE | DANISH.KRONE | 0% |
 AUSTRALIAN DOLLAR | AUSTRALIAN.DOLLAR | 0% |
 EURO | EURO | 0% |
 SWISS FRANC | SWISS.FRANC | 0% |
 GREAT BRITISH POUND | GREAT.BRITISH.POUND | 0% |
| Sector | Weight |
|---|---|
|
Health care | 91.05% |
|
Materials | 4.00% |
|
Consumer staples | 3.54% |
|
Financials | 1.40% |
WisdomTree BioRevolution Fund (WDNA) share price today is $22.72.
Yes, Indians can buy shares of WisdomTree BioRevolution Fund (WDNA) on Vested. To buy WDNA from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of WisdomTree BioRevolution Fund (WDNA) on Vested. You can start investing in WisdomTree BioRevolution Fund (WDNA) with a minimum investment of $1.
The 52-week high price of WisdomTree BioRevolution Fund (WDNA) is $24.74. The 52-week low price of WisdomTree BioRevolution Fund (WDNA) is $15.
The stock symbol (or ticker) of WisdomTree BioRevolution Fund is WDNA.
Yes, you can setup SIP in WisdomTree BioRevolution Fund shares. Follow the below steps to create the SIP:
Here is the historical performance of WDNA on the Vested app.
The expense ratio of WisdomTree BioRevolution Fund (WDNA) is 0.45%.
Link copied 
